Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
07/2003
07/24/2003US20030139467 Diuretics containing y-tocotrienol
07/24/2003US20030139463 Anticancer agents; antiarthritic agents
07/24/2003US20030139462 Antiinflammatory agents; autoimmune disease; antiarthritic agents
07/24/2003US20030139458 Stroke; Alzheimer's disease; Parkinson's disease; Huntington's disease
07/24/2003US20030139455 Amlodipine salt forms and processes for preparing them
07/24/2003US20030139453 Difluorobutyric acid metalloprotease inhibitors
07/24/2003US20030139452 Pyrazole-derived kinase inhibitors and uses thereof
07/24/2003US20030139451 Synthesis and anti-tumor activity of nitrogen substituted thalidomide analogs
07/24/2003US20030139447 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
07/24/2003US20030139439 Uses of diterpenoid triepoxides as an anti-proliferative agent
07/24/2003US20030139435 N-heterocyclic inhibitors of TNF-alpha expression
07/24/2003US20030139428 Purine derivatives for treatment of gastrointestinal disorders, immunological disorders, neurological disorders
07/24/2003US20030139419 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
07/24/2003US20030139417 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof
07/24/2003US20030139413 Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical composition containing them
07/24/2003US20030139410 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
07/24/2003US20030139407 Efficient synthesis of 5-heteroatom-containing -pyrazoles
07/24/2003US20030139406 Antiinflammatory agents; antidepressants; respiratory system disorders; cognition activators
07/24/2003US20030139405 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
07/24/2003US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders
07/24/2003US20030139401 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
07/24/2003US20030139400 Controlling cell differentiation; antiinflammatory agents
07/24/2003US20030139399 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
07/24/2003US20030139398 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
07/24/2003US20030139394 Dibenzodiazepine derivatives, their preparation and use
07/24/2003US20030139389 Gastrointestinal disorders, cardiovascular disorders, central nervous system disorders
07/24/2003US20030139384 Transdermal supplying testosterone
07/24/2003US20030139376 Lipoxin A4 analogs
07/24/2003US20030139371 Drug for combating sexual dysfunctions
07/24/2003US20030139368 Antithrombotic and/or anti-inflammatory composition combining purine activity and NSAID activity
07/24/2003US20030139355 Medicine for orthopaedic surgical application and a treating method using thereof
07/24/2003US20030139353 Using topoisomerase inhibitor; antiarthritic agents; respiratory system disorders; skin disorders
07/24/2003US20030139350 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents
07/24/2003US20030138926 Novel polynucleotides and polypeptides encoded thereby
07/24/2003US20030138815 Cyclic adenosine monophosphate (cAMP); drug screening; bronchodilators; antiinflammatory agents; immunomodulators; antiallergens; bioassays
07/24/2003US20030138772 Polymerase chain reactions to screen and isolate parvovirus DNA obtained from tissue and/or cells without coinfection by helper viruses; gene therapy
07/24/2003US20030138503 Topical pharmaceutical formulations and methods of treatment
07/24/2003US20030138486 A solid time-release oral medicine comprising a controlled release agent to maintain a low bulk density, for increasing the gastric residence time of the drug
07/24/2003US20030138476 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall
07/24/2003US20030138407 Therapeutic methods for nucleic acid delivery vehicles
07/24/2003CA2474239A1 Substituted pyridazinones as inhibitors of p38
07/24/2003CA2474141A1 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
07/24/2003CA2474127A1 4-oxo-4, 7-dihydrofuro¬2,3-b|pyridine-5-carboxamide antiviral agents
07/24/2003CA2473893A1 Stable salts of o-acetylsalicylic acid with basic amino acids ii
07/24/2003CA2473447A1 Solid salts of benzazepine compounds and their use in the preparation of pharmaceutical compounds
07/24/2003CA2473362A1 Substituted alkyl uracils and the use thereof
07/24/2003CA2473236A1 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues
07/24/2003CA2472993A1 Oxothieno (3, 2-b) pyridinecarboxamides as antiviral agents
07/24/2003CA2472746A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
07/24/2003CA2472619A1 Fused pyrimidine derivates as rho-kinase inhibitors
07/24/2003CA2472470A1 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
07/24/2003CA2472469A1 1,3-disubstituted and 1,3,3,-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
07/24/2003CA2472419A1 Coumarin derivatives, process for their production and use thereof
07/24/2003CA2472377A1 Crystalline solids of carvedilol and processes for their preparation
07/24/2003CA2472223A1 Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to pparalpha activation
07/24/2003CA2472209A1 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity
07/24/2003CA2472204A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
07/24/2003CA2472168A1 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
07/24/2003CA2471480A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
07/24/2003CA2471311A1 Aromatic thioether liver x-receptor modulators
07/24/2003CA2471309A1 Synthesis of combretastatin a-2 prodrugs
07/24/2003CA2470970A1 Post-conditioning for the reduction of ischemic-reperfusion injury in the heart and other organs
07/24/2003CA2470649A1 Mmp inhibitors
07/24/2003CA2470571A1 Povidone-containing carriers for polypeptide growth factors
07/24/2003CA2470503A1 Compositions and methods for promoting myocardial and peripheral angiogenesis
07/24/2003CA2469472A1 Endothelial stem cells, populations, methods of isolation and use thereof
07/24/2003CA2469435A1 Modulators of lxr
07/24/2003CA2464805A1 D-tagatose as an anti-biofilm agent
07/23/2003EP1329511A1 Polypeptide having phospholipase a2 actiivty
07/23/2003EP1329508A1 Novel g protein-coupled receptor protein and dna thereof
07/23/2003EP1329458A2 Peptides that lower blood glucose levels
07/23/2003EP1329450A1 Benzodiazepine derivative
07/23/2003EP1329223A1 Expression potentiator for protein synthesis regulatory gene
07/23/2003EP1329222A1 Isoflavone compositions for use in medicine
07/23/2003EP1329218A1 Preventives/remedies for portal hypertension
07/23/2003EP1329217A1 Solid preparations
07/23/2003EP1328816A2 Regulation of neutral development by daedalos
07/23/2003EP1328653A2 Highly expressible genes
07/23/2003EP1328646A2 Regulation of human adenylate cyclase, type iv
07/23/2003EP1328634A2 Genes expressed in the cell cycle
07/23/2003EP1328630A2 Secreted proteins
07/23/2003EP1328629A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
07/23/2003EP1328624A2 B7-like molecules and uses thereof
07/23/2003EP1328622A2 Protein c or activated protein c-like molecules
07/23/2003EP1328619A1 Human tuberoinfundibular peptide of 39 residues
07/23/2003EP1328548A2 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
07/23/2003EP1328546A2 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator
07/23/2003EP1328539A1 Vegf peptides and their use for inhibiting angiogenesis
07/23/2003EP1328526A1 3,8-diazabicyclo[3.2.1]octanes and their use in the treatment of cardiac arrhythmias
07/23/2003EP1328525A2 2,3,4,5-tetrahydro-1h-[1,4]diazepino[1,7-a]indole compounds
07/23/2003EP1328524A2 Novel anticholinergics, method for the production thereof and use thereof as medicaments
07/23/2003EP1328522A2 Estrogen receptor modulators
07/23/2003EP1328521A2 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride
07/23/2003EP1328519A2 Orally active salts with tyrosine kinase activity
07/23/2003EP1328516A1 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds
07/23/2003EP1328515A1 Indoline derivatives and their use as 5-ht2 receptor ligands
07/23/2003EP1328514A1 Amide derivatives as nmda receptor antagonists
07/23/2003EP1328511A1 Substituted (e)-styryl benzylsulfones for treating proliferative disorders
07/23/2003EP1328508A2 Propionic acid derivatives with ppar-alpha activating properties
07/23/2003EP1328294A2 Combination use of acetylcholinesterase inhibitors and gaba-a inverse agonists for the treatment of cognitive disorders
1 ... 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 ... 1595